Upstream Bio (UPB) Operating Leases (2024 - 2026)

Upstream Bio's Operating Leases history runs 3 years deep, the most recent figure standing at $390000.0 for Q1 2026.

• In Q1 2026, Operating Leases fell 60.69% year-over-year to $390000.0; the TTM figure through Mar 2026 stood at $390000.0 (down 60.69% YoY), while the FY2025 annual figure was $549000.0, down 51.42% from the prior year.
• Operating Leases was $390000.0 for Q1 2026 at Upstream Bio, down from $549000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.3 million in Q3 2024 to a low of $390000.0 in Q1 2026.
• Historically, Operating Leases has averaged $839428.6 across 3 years, with a median of $849000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Operating Leases sank 44.34% in 2025, then plunged 60.69% in 2026.
• A 3-year view of Operating Leases shows it stood at $1.1 million in 2024, then slumped by 51.42% to $549000.0 in 2025, then decreased by 28.96% to $390000.0 in 2026.
• The last three Operating Leases figures came in at $390000.0 (Q1 2026), $549000.0 (Q4 2025), and $703000.0 (Q3 2025), per Business Quant data.